Dolutegravir and lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48 weeks results of a pilot clinical trial (TRAPRO)

Rial, Diego; Miguel, Rosa de; Domínguez Domínguez, Lourdes; Montejerano, R.; Esteban Cantos, Andrés; Bisbal, Otilia; Stella Ascariz, Natalia; Aranguren Rivas, Paula; Bermejo Plaza, C.; García Álvarez, M.; Alejos, Belén; Hernando Jeréz, María Asunción; Mayoral, M.; Castro, J. M.; Moreno, Víctor; Martín Carbonero, Luz; Delgado, Rafael; Rubio, Rafael; Pulido, Federico; Arribas, José R.

doi:10.1016/j.ebiom.2020.102779

Home

dc.contributor.author	Rial, Diego
dc.contributor.author	Miguel, Rosa de
dc.contributor.author	Domínguez Domínguez, Lourdes
dc.contributor.author	Montejerano, R.
dc.contributor.author	Esteban Cantos, Andrés
dc.contributor.author	Bisbal, Otilia
dc.contributor.author	Stella Ascariz, Natalia
dc.contributor.author	Aranguren Rivas, Paula
dc.contributor.author	Bermejo Plaza, C.
dc.contributor.author	García Álvarez, M.
dc.contributor.author	Alejos, Belén
dc.contributor.author	Hernando Jeréz, María Asunción
dc.contributor.author	Mayoral, M.
dc.contributor.author	Castro, J. M.
dc.contributor.author	Moreno, Víctor
dc.contributor.author	Martín Carbonero, Luz
dc.contributor.author	Delgado, Rafael
dc.contributor.author	Rubio, Rafael
dc.contributor.author	Pulido, Federico
dc.contributor.author	Arribas, José R.
dc.date.accessioned	2020-02-11T10:38:52Z
dc.date.available	2020-02-11T10:38:52Z
dc.date.issued	2019
dc.identifier.citation	Rial-Crestelo, D., de Miguel Buckley, R., Domínguez Domínguez, L., Montejerano, R., Esteban, A., Bisbal, O., Hernando Jerez, M. A., …Arribas, J. R. (2019). Dolutegravir and lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48 weeks results of a pilot clinical trial (TRAPRO). Enfermedades Infecciosas y Microbiología Clínica, 37(especial), 81-82. https://doi.org/10.1016/j.ebiom.2020.102779	spa
dc.identifier.issn	0213-005X
dc.identifier.uri	http://hdl.handle.net/11268/8585
dc.description.sponsorship	Plan Nacional PI16-00678	spa
dc.language.iso	eng	spa
dc.title	Dolutegravir and lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48 weeks results of a pilot clinical trial (TRAPRO)	spa
dc.type	poster	spa
dc.description.impact	1.654 JCR (2019) Q4, 79/92 Infectious Diseases	spa
dc.description.impact	0.317 SJR (2019) Q3, 83/128 Microbiology (medical)	spa
dc.description.impact	No data IDR 2019	spa
dc.identifier.doi	10.1016/j.ebiom.2020.102779	spa
dc.rights.accessRights	closedAccess	spa
dc.subject.uem	VIH (Virus)	spa
dc.subject.uem	Farmacología	spa
dc.subject.unesco	Sida	spa
dc.subject.unesco	Farmacología	spa
dc.description.filiation	UEM	spa
dc.peerreviewed	Si	spa